Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

20.6K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
20.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy.

Gene therapy·2026
Same author

The p.(Leu97Ile) variant expands the genetic landscape of NEFL-associated Charcot-Marie-tooth neuropathies.

Human molecular genetics·2026
Same author

Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multi-omic analyses of a syndrome variably associated with systemic sclerosis.

Acta neuropathologica·2026
Same author

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans.

Cell reports. Medicine·2026
Same author

A muscular dystrophy associated with bi-allelic LEMD2 variants: Expanding the genotype of nuclear envelopathies.

Brain pathology (Zurich, Switzerland)·2026
Same author

Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy.

Communications biology·2026

Related Experiment Video

Updated: Mar 12, 2026

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
06:55

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Published on: June 7, 2020

3.4K

Sil1-Mutant Mice Elucidate Chaperone Function in Neurological Disorders.

Stephan Buchkremer1, José Andrés González Coraspe1, Joachim Weis1

  • 1Institute of Neuropathology, University Hospital RWTH Aachen, Aachen, Germany.

Journal of Neuromuscular Diseases
|November 18, 2016
PubMed
Summary

The Sil1-mutant woozy mouse model reveals endoplasmic reticulum chaperone dysfunction mechanisms impacting nervous system and skeletal muscle. This model aids research into Marinesco-Sjögren syndrome and neuroprotective co-chaperone functions.

Keywords:
BiPcerebellar ataxiachaperonevacuolar myopathywoozy mouse

More Related Videos

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

21.1K
Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

7.7K

Related Experiment Videos

Last Updated: Mar 12, 2026

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
06:55

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Published on: June 7, 2020

3.4K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

21.1K
Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

7.7K

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Chaperone dysfunction causes protein misfolding, affecting the nervous system and skeletal muscle.
  • Understanding chaperone function is crucial for treating genetic and acquired chaperonopathies.
  • Lack of suitable animal models hinders research into chaperone dysfunction mechanisms.

Purpose of the Study:

  • To introduce the Sil1-mutant woozy mouse as a model for impaired endoplasmic reticulum (ER) chaperone function.
  • To investigate molecular and cellular mechanisms affecting nervous system and skeletal muscle integrity.
  • To explore the utility of this model for studying neuroprotective co-chaperone function.

Main Methods:

  • Characterization of the Sil1-mutant woozy mouse model.
  • Analysis of molecular and cellular abnormalities in nervous system and skeletal muscle.
  • Biochemical investigation of nuclear envelope alterations.
  • Assessment of Purkinje cell survival pathways.

Main Results:

  • The woozy mouse model closely mimics human Marinesco-Sjögren syndrome.
  • Confirmed ER-stress and identified altered nuclear envelope in muscle, characteristic of SIL1-disease.
  • Suggests impaired excitation-contraction coupling in SIL1-pathophysiology.
  • Identified divergent pro- and anti-survival protein expression influencing Purkinje cell survival.

Conclusions:

  • The woozy mouse is a valuable model for studying ER-chaperone dysfunction in neurodegenerative and neuromuscular disorders.
  • This model facilitates research into neuroprotective co-chaperone roles and co-chaperone involvement in conditions like diabetic neuropathy.
  • Further investigation of SIL1-pathophysiology can inform therapeutic strategies for chaperonopathies.